The Analyst Landscape: 17 Takes On BioNTech
The Analyst Landscape: 17 Takes On BioNTech
分析師視角：關於biontech的17個看法
The standing of BioNTech among financial experts becomes clear with a thorough analysis of recent analyst...Analysts' ratings for BioNTech (NASDAQ:BNTX) over the last quarter vary from bullish to bearish, as provided by 17 analysts.
過去季度對biontech (納斯達克:BNTX) 的分析師評級從看好到看淡不一，由17位分析師提供。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for BioNTech, revealing an average target of $132.24, a high estimate of $171.00, and a low estimate of $96.00. Marking an increase of 19.2%, the current average surpasses the previous average price target of $110.94.
分析師爲biontech設定了12個月的價格目標，顯示平均目標爲$132.24，最高估價爲$171.00，最低估價爲$96.00。當前平均值比之前的$110.94的價格目標高出19.2%。
Exploring Analyst Ratings: An In-Depth Overview
分析師評級:深入了解
The standing of BioNTech among financial experts becomes clear with a thorough analysis of recent analyst...
通過近期分析師行動的徹底分析，生...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間